CGON — CG ONCOLOGY INC

Ownership history in BRAIDWELL LP  ·  8 quarters on record

This page tracks every 13F SEC filing in which BRAIDWELL LP reported a position in CG ONCOLOGY INC (CGON). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
3.92% (2025 Q3)
Avg. % of fund
2.9%
First filed
2024 Q1
Last filed
2025 Q4
Quarters held
8
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 1,870,571 -1,412,746 -43.0% 2.48% $77.7M $41.52
2025 Q3 UNCHANGED 3,283,317 — 0% 3.92% $132.3M $40.28
2025 Q2 UNCHANGED 3,283,317 — 0% 2.92% $85.4M $26.00
2025 Q1 UNCHANGED 3,283,317 — 0% 2.83% $80.4M $24.49
4 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    CGON price (monthly, adj. close)

Other funds also holding CGON

As of 2025 Q4 — sorted by position size

Seven Fleet Capital Management LP 47.85% Decheng Capital LLC 35.59% Foresite Capital Management V, LLC 3Y 25.36% Avidity Partners Management LP 3Y 17.64% ACORN CAPITAL ADVISORS, LLC 15.92% Elmind Capital, LP 6.03% TCG Crossover Management, LLC 3Y 5.04% Rosalind Advisors, Inc. 4.38% Octagon Capital Advisors LP 3Y 3.02% Kynam Capital Management, LP 3Y 2.51%
← Back to BRAIDWELL LP Holdings